Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Himachalol is a himachalane-type **sesquiterpenoid alcohol** (C15H26O) found in the essential oil of the Himalayan cedar (Cedrus deodara) and other plant sources.[1][2][8][15] It occurs naturally as both cis- and trans-isomers, with structural and spectroscopic differences. Himachalol has demonstrated **antispasmodic, anticancer, insecticidal**, and *antifungal* properties in vitro and in experimental studies.[3][5][7][8][11] Its antispasmodic activity is associated with antagonism of neurotransmitters such as acetylcholine, histamine, and serotonin on smooth muscle, similar to papaverine.[5][7] The mechanism of action is not fully elucidated but likely involves **smooth muscle relaxation via neurotransmitter antagonism**.[3][5][7] Himachalol (especially cis-isomer) has shown **cytotoxicity against several cancer cell lines** in preclinical assays and demonstrated **activity against Aspergillus species** in vitro.[5][11]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on himachalol.